Skip to main content

Annals of Hematology

Ausgabe 9/2018

Inhalt (33 Artikel)

Review Article

Copper deficiency anemia: review article

Zin W. Myint, Thein H. Oo, Kyaw Z. Thein, Aung M. Tun, Hayder Saeed

Open Access Original Article

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL

Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, Shigeki Ohtake, Masako Iwanaga, Isamu Sugiura, Noriko Doki, Heiwa Kanamori, Yasunori Ueda, Chikamasa Yoshida, Nobuaki Dobashi, Tomoya Maeda, Toshiaki Yujiri, Fumihiko Monma, Yoshikazu Ito, Fumihiko Hayakawa, Jin Takeuchi, Hitoshi Kiyoi, Yasushi Miyazaki, Tomoki Naoe

Original Article

Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins

Alfonso Vignoli, Marina Marchetti, Anna Falanga

Original Article

Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients

Elsa M. Cardoso, André J. Esgalhado, Luís Patrão, Mónica Santos, Vasco Pinto Neves, Jorge Martinez, Maria Assunção Vaz Patto, Helena Silva, Fernando A. Arosa

Original Article

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

Massimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, Massimiliano Bonifacio, Domenica Gangemi, Federica Sorà, Alessandra Iurlo, Luigiana Luciano, Antonella Gozzini, Massimo Gentile, Monica Bocchia, Debora Luzi, Alessandro Maggi, Nicola Sgherza, Alessandro Isidori, Monica Crugnola, Patrizia Pregno, Anna Rita Scortechini, Isabella Capodanno, Michele Pizzuti, Robin Foà

Original Article

The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology

Ljubomir Jakovic, Mirjana Gotic, Heinz Gisslinger, Ivan Soldatovic, Dijana Sefer, Mila Tirnanic, Danijela Lekovic, Maja Perunicic Jovanovic, Martin Schalling, Bettina Gisslinger, Christine Beham-Schmid, Ingrid Simonitsch-Klupp, Jürgen Thiele

Open Access Original Article

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

Martin Griesshammer, Guray Saydam, Francesca Palandri, Giulia Benevolo, Miklos Egyed, Jeannie Callum, Timothy Devos, Serdar Sivgin, Paola Guglielmelli, Caroline Bensasson, Mahmudul Khan, Julian Perez Ronco, Francesco Passamonti

Original Article

Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence

Corentin Orvain, Francois Beloncle, Jean-Francois Hamel, Aurélien Sutra Del Galy, Sylvain Thépot, Mélanie Mercier, Achille Kouatchet, Jonathan Farhi, Sylvie Francois, Norbert Ifrah, Alain Mercat, Pierre Asfar, Mathilde Hunault-Berger, Aline Tanguy-Schmidt

Original Article

The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders

Satoshi Takanashi, Tomonori Nakazato, Yoshinobu Aisa, Chisako Ito, Hideki Arakaki, Yuki Osada, Motoharu Hirano, Takehiko Mori

Original Article

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience

Chiara Ciochetto, Barbara Botto, Roberto Passera, Marilena Bellò, Giulia Benevolo, Carola Boccomini, Alessia Castellino, Annalisa Chiappella, Roberto Freilone, Maura Nicolosi, Lorella Orsucci, Clara Pecoraro, Patrizia Pregno, Gianni Bisi, Umberto Vitolo

Open Access Original Article

Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature

Nyanza K. L. M. Timmers, Josanne S. de Maar, Rob C. M. van Kruijsdijk, Saskia K. Klein

Original Article

Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma

Marc Sorigue, Francisco Gual-Capllonch, Olga Garcia, Edurne Sarrate, Mireia Franch-Sarto, Gladys Ibarra, Javier Grau, Elisa Orna, Josep-Maria Ribera, Juan-Manuel Sancho

Original Article

Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease

Yujun Dong, Lu Zhang, Lin Nong, Lihong Wang, Zeyin Liang, Daobin Zhou, David C. Fajgenbaum, Hanyun Ren, Jian Li

Open Access Original Article

Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients

Eric P. Allain, Karin Venzl, Patrick Caron, Véronique Turcotte, David Simonyan, Michaela Gruber, Trang Le, Eric Lévesque, Chantal Guillemette, Katrina Vanura

Original Article

A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion

Yuqing Miao, Yi Miao, Ke Shi, Qian Sun, Si-Shu Zhao, Yi Xia, Shu-Chao Qin, Hai-Rong Qiu, Hui Yang, Hao Xu, Hua-Yuan Zhu, Jia-Zhu Wu, Wei Wu, Lei Cao, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li

Open Access Original Article

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Eirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, Despoina Kyriakou, Argiris Symeonidis, Emmanouil Spanoudakis, Georgios Vasilopoulos, Achilles Anagnostopoulos, Anna Kioumi, Panagiotis Zikos, Anthi Aktypi, Evangelos Briasoulis, Aikaterini Megalakaki, Panayiotis Repousis, Ioannis Adamopoulos, Dimitrios Gogos, Maria Kotsopoulou, Vassiliki Pappa, Eleni Papadaki, Despoina Fotiou, Eftychia Nikolaou, Evlambia Giannopoulou, Eleftheria Hatzimichael, Nikolaos Giannakoulas, Vassiliki Douka, Kyriaki Kokoviadou, Despoina Timotheatou, Evangelos Terpos

Original Article

− 174 G>C IL-6 polymorphism and primary iron overload in male patients

Walter F. Tetzlaff, Tomás Meroño, Eliana E. Botta, Maximiliano E. Martín, Patricia B. Sorroche, Laura E. Boero, Marcelo Castro, Gustavo D. Frechtel, Jorge Rey, Jorge Daruich, Gloria E. Cerrone, Fernando Brites

Original Article

Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia

Siddhesh Arun Kalantri, Rudra Ray, Arnab Chattopadhyay, Sunistha Bhattacharjee, Ankita Biswas, Maitreyee Bhattacharyya

Original Article

Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A

Hyun-Young Kim, Jin-Hee Cho, Hee-Jung Kim, Hae-Sun Chung, Sun-Hee Kim, Ki-O Lee, Soo-Young Jung, Ki-Young Yoo, Hee-Jin Kim

Open Access Original Article

Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation

Mingming Qu, Qiang Liu, Hong-Guo Zhao, Jun Peng, Heyu Ni, Ming Hou, A. J. Gerard Jansen

Original Article

Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies

Bernard Tawfik, Larry Brown, Frankling Fuda, Weina Chen, Shuang Niu, Joseph Sailors, Navid Sadeghi

Original Article

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria

C. Cattaneo, R. Di Blasi, C. Skert, A. Candoni, B. Martino, N. Di Renzo, M. Delia, S. Ballanti, F. Marchesi, V. Mancini, E. Orciuolo, S. Cesaro, L. Prezioso, R. Fanci, G. Nadali, A. Chierichini, L. Facchini, M. Picardi, M. Malagola, V. Orlando, E. M. Trecarichi, M. Tumbarello, F. Aversa, G. Rossi, L. Pagano, Angela Passi, Doriana Gramegna, Domenico Russo, Davide Lazzarotto, Domenico Rotilio, Maria Rosaria De Paolis, Edoardo Simonetti, Maria Alessandra Innocente, Antonio Spadea, Francesco Mazziotta, Anna Pegoraro, Angelica Spolzino, Gloria Turri, Barbara Veggia

Letter to the Editor

Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?

Narendranath Epperla, Ariel Kleman, Matthew Karafin, Patrick Foy

Letter to the Editor

SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation

Jieun Kim, In Sik Hwang, Saeam Shin, Jong Rak Choi, Seung-Tae Lee

Letter to the Editor

Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia

Anissa Moktefi, Caroline Dudreuilh, Jean Michel Goujon, Nathalie Quellard, Jean Marc Zini, Vincent Audard, Philippe Rémy

Letter to the Editor

Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome

Ana Villalba, Julieta Osorio, Carmen Freiria, Marta Santiago, Blanca Boluda, Ana I. Vicente, Amparo Sempere, Rafa Andreu, Federico Gomis, Leonor Senent

Letter to the Editor

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase

Junko Watanabe, Shinichi Makita, Yuta Ito, Shunsuke Hatta, Tomotaka Suzuki, Sayako Yuda, Akiko Miyagi Maeshima, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Sung-Won Kim, Koji Izutsu

Letter to the Editor

Massive hemolysis complicating acute granulomatous hepatitis

Adrià Carpio, Anna Merino, Sergio Rodríguez-Tajes, Enric Reverter, Miquel Bruguera, Xavier Forns, Javier Fernández

Correction

Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study

Zara Forbrigger, Stefan Kuhle, Mary Margaret Brown, Paul C. Moorehead, Carol Digout, Ketan Kulkarni

Correction

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

Alexander Egle, Michael Steurer, Thomas Melchardt, Lukas Weiss, Franz Josef Gassner, Nadja Zaborsky, Roland Geisberger, Kemal Catakovic, Tanja Nicole Hartmann, Lisa Pleyer, Daniela Voskova, Josef Thaler, Alois Lang, Michael Girschikofsky, Andreas Petzer, Richard Greil

Correction

Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Eirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, Despoina Kyriakou, Argiris Symeonidis, Emmanouil Spanoudakis, Georgios Vasilopoulos, Achilles Anagnostopoulos, Anna Kioumi, Panagiotis Zikos, Anthi Aktypi, Evangelos Briasoulis, Aikaterini Megalakaki, Panayiotis Repousis, Ioannis Adamopoulos, Dimitrios Gogos, Maria Kotsopoulou, Vassiliki Pappa, Eleni Papadaki, Despoina Fotiou, Eftychia Nikolaou, Evlambia Giannopoulou, Eleftheria Hatzimichael, Nikolaos Giannakoulas, Vassiliki Douka, Kyriaki Kokoviadou, Despoina Timotheatou, Evangelos Terpos

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.